CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 360 enrolled
Drug / intervention
sevelamer phosphate-binders +1 moredrug
Likely dose
sevelamer phosphate-binders 1600 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00710788
NCT00710788N/ACompleted
CompareCT.gov

Interventional, Multicenter, Prospective, Randomized Trial to Slow Down the Progression of Cardiovascular Calcifications to Reduce QTd in Incident Dialysis Patients

Azienda Sanitaria ASL Avellino 2·interventional·Posted Jul 4, 2008·Updated Feb 12, 2013

In Brief

A clinical study evaluating sevelamer phosphate-binders and Calcium Carbonate for Cardiovascular Mortality. Completed, enrolled 360 participants across 1 site.

Detailed Summary

Research proposal to evaluate the impact of different phosphate binders on the progression of cardiovascular calcification and QT dispersion in new haemodialysis patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Mortality
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 4, 2008
Enrollment StartJan 1, 2007
Primary CompletionSep 1, 2010
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 18.0 years ago

Interventions

sevelamer phosphate-bindersdrug

1600 mg/day for 2 years

Calcium Carbonatedrug

Calcium carbonate 1 g/day for 2 years